Skip to content

Auriculotherapy for postpartum pain relief – a randomized clinical trial

Efficacy and acceptance of auriculotherapy for pain relief in the immediate postpartum period at the university hospital of Florianópolis - a pilot randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-106nnmgg
Enrollment
Unknown
Registered
2025-05-07
Start date
2025-05-29
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acupuncture Analgesia

Interventions

This is an open-label, randomized controlled clinical trial with two arms. Participants will be postpartum women following either vaginal delivery or cesarean section who meet the selection criteria.
E02.190.044.133

Sponsors

Universidade Federal de Santa Catarina
Lead Sponsor
Universidade Federal de Santa Catarina
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Vaginal delivery or cesarean section performed at Universitary Hospital (HU) of Universidade Federal de Santa Catarina (UFSC); age between 18 and 50 years; live newborn; agreement to participate in the study; sign the informed consent form

Exclusion criteria

Exclusion criteria: Severe medical complications in the postpartum period; history of severe psychiatric disorders or cognitive impairment; presence of piercings or similar items at the acupuncture point sites; contraindications for auricular acupuncture (infections at the application site, known allergies); additional surgeries or procedures (tubal ligation, hysterectomy)

Design outcomes

Primary

MeasureTime frame
As assessed through a participant interview on the day after delivery, a difference of at least 30% in the request for additional analgesics between the groups is expected.

Secondary

MeasureTime frame
The intervention group expects a reduction of at least one point in the average pain level throughout the postpartum period, as assessed by the Visual Analog Scale for Pain and reported by the puerperal individual on the day after delivery or cesarean section.;Espera-se que a maioria das participantes do grupo de intervenção (mais de 75%) considerem o tratamento como aceitável, mensurada por uma escala Likert de aceitação, no dia seguinte ao parto.;It is expected that the intervention group will show an increase of at least 20% in vagal activity compared to the control group, as assessed by the high-frequency component (HF, normalized) of Heart Rate Variability, measured by a heart rate monitor and heart rate variability measurement software.

Countries

Brazil

Contacts

Public ContactRoxana Knobel

Universidade Federal de Santa Catarina

roxana.knobel@ufsc.br+554837219104

Outcome results

None listed

Source: REBEC (via WHO ICTRP)